Target intelligence / Profile preview

TATA-box binding protein associated factor 13 pseudogene 2 (TAF13P2)

Target
TAF13P2
Molecular classification
Other (Pseudogene)
01

Overview

TATA-box binding protein associated factor 13 pseudogene 2 (TAF13P2) is annotated as a pseudogene, meaning it is a non-functional genomic sequence similar to the protein-coding TAF13 gene but does not encode a functional protein[6][4]. TAF13P2 has no known biological function, molecular activity, or role as a drug target. It has no described disease associations, nor does it interact with drugs or serve as a biomarker. Its only significance is as a noncoding genomic element related in sequence to the functional TAF13 gene, which is a component of the transcription factor IID (TFIID) complex essential for RNA polymerase II transcription[6][4]. Note: - There is nothing to suggest TAF13P2 is a therapeutic target, druggable protein, or disease-associated locus. It is a processed pseudogene—functionally inert in protein-coding and signaling roles. - If you intended to refer to the functional TAF13 gene/protein, please clarify; TAF13 itself is involved in transcriptional regulation but TAF13P2 is not[1][2][6].

Other names
TAF13 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 18kDa pseudogene 2TAF13P2
02

Mechanism of action

Not applicable

03

Biological functions

None (pseudogenes are generally non-functional and do not produce a functional protein)
04

Disease associations

None known; pseudogenes rarely play direct roles in disease as functional protein-coding genes would
05

Safety considerations

None known
06

Interacting drugs

None
07

Biomarkers

None known

Beyond the preview

Go deeper on TATA-box binding protein associated factor 13 pseudogene 2 (TAF13P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TATA-box binding protein associated factor 13 pseudogene 2 (TAF13P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call